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SUMMARY
A 64-year-old woman with chronic right arm
lymphoedema presented with progressive and painful
vision loss in the right eye following diagnosis of
erysipelas in the ipsilateral arm. Visual acuity was light
perception. Biomicroscopy revealed marked conjunctival
injection, decreased corneal transparency and an
inﬂammatory mass in the anterior chamber, which
precluded fundoscopy. The ocular ultrasonography
features were consistent with acute endophthalmitis, and
the patient was admitted to the hospital. A systemic
evaluation, including complete physical examination,
echocardiography and blood tests, ruled out other
sources of infection besides the cutaneous site. Blood
cultures were positive for group A Streptococcus.
A diagnosis of unilateral acute endophthalmitis due
to group A Streptococcus bacteraemia secondary to
erysipelas was made and successfully treated with
optimal medical care, including prompt intravitreal and
systemic antibiotic administration. Despite resolution of
the infectious process, visual acuity did not improve.
BACKGROUND
Endogenous endophthalmitis (EE) secondary to
cutaneous infection is a rare occurrence, with about
30 cases found in the literature. Erysipelas is a
superﬁcial dermal infectious process that, despite a
relatively benign clinical appearance, can lead to
septicaemia and endogenous endophthalmitis.
Owing to the rare and sight-threatening nature of
this disease, we felt obliged to report it. We believe
that a cutaneous source of infection should always
be sought whenever an endogenous endophthalmi-
tis is suspected, so that timely institution of optimal
medical care can be provided to the patients.
CASE PRESENTATION
A 64-year-old woman presented to her general
practitioner due to an inﬂammatory lesion on her
right arm, with redness, swelling and well-
demarcated borders, compatible with erysipelas
(ﬁgure 1). She had a history of right mastectomy
due to stage IIB breast cancer 24 years before, with
secondary chronic lymphoedema of the ipsilateral
arm. A non-steroidal anti-inﬂammatory and oral
ﬂucloxacillin were prescribed for the infection.
Four days later, the patient was seen at the oph-
thalmology emergency room with progressive and
painful vision loss in her right eye (OD) associated
with redness and tearing. There was no history of
trauma, recent ocular surgery or drug abuse. Right
arm erysipelas showed no improvement and add-
itional foci of infection had developed in both feet.
The patient was febrile (axillary temperature
38.6°C). Best-corrected visual acuity was light per-
ception OD and 6/6 (Snellen) in the left eye.
Biomicroscopy revealed conjunctival injection,
corneal oedema and an inﬂammatory inﬁltrate in
the anterior chamber, along with a mid-dilated
non-reactive pupil (ﬁgure 2). Fundoscopy was
impossible due to decreased media transparency
but ocular ultrasonography showed severe vitritis
without retinal detachment. Left eye examination
was unremarkable.
A diagnosis of acute unilateral endogenous
endophthalmitis was made and the patient was
admitted to the hospital for medical treatment.
Figure 1 Right arm with a red cutaneous plaque with
well-demarcated edges, typical of erysipelas.
Figure 2 Slit-lamp photograph of the right eye on
admission.
Costa JF, et al. BMJ Case Rep 2015. doi:10.1136/bcr-2014-209252 1
Unusual association of diseases/symptoms
INVESTIGATIONS
A multidisciplinary approach was used to identify possible
sources of infection besides erysipelas. The patient was fully eval-
uated by a team of cardiologists, dermatologists and infectolo-
gists. Blood tests showed leucocytosis (25.1×109/L) and elevated
C reactive protein (339.3 mg/L). Chest X-ray, ECG and abdom-
inal ultrasound were unremarkable, and no signs of endocarditis
were found on echocardiography. Urine, vitreous and anterior
chamber tap cultures found no causative agent. Three days after
admission, blood cultures grew group A Streptococcus.
TREATMENT
Immediately after admission, the patient underwent intravitreal
injections of vancomycin (1 mg in 0.1 mL) and ceftazidime
(2 mg in 0.1 mL). Owing to an initial poor clinical response,
this procedure was repeated 48 h later. Hourly fortiﬁed topical
tobramycin and vancomycin were used, along with endovenous
meropenem (1 g q8h). Owing to corneal oedema it was not pos-
sible to safely perform an adjuvant pars plana vitrectomy.
Antibiotic susceptibility testing of the isolated Group A strepto-
cocci showed sensitivity to meropenem, so the antibiotic
regimen was continued for 14 days and no further intravitreal
antibiotics were administered.
OUTCOME AND FOLLOW-UP
Daily re-evaluation showed slow improvement of the cutaneous
infection, along with gradual resolution of the intraocular
inﬂammatory signs after 72 h of antibiotherapy. Erysipelas
remained the only recognisable source of septicaemia. One
month after discharge, the patient was asymptomatic. The
cornea was opaque and rubeosis iridis was noted, but there was
no intraocular hypertension. Persistent vitreous condensations
precluded fundus visualisation. Best-corrected visual acuity
remained light perception. The patient refused pars plana vitrec-
tomy and penetrating keratoplasty, and was later lost to
follow-up.
DISCUSSION
Endophthalmitis is one of the most feared disorders in ophthal-
mology. It is an inﬂammatory condition of the eye due to an
intraocular infectious process caused by bacteria, fungi or,
rarely, parasites. It can be classiﬁed as exogenous or endogenous
depending on the underlying physiopathological mechanism.
Exogenous endophthalmitis, the most common of the two,
arises due to a disruption of the external ocular barriers follow-
ing trauma or surgery. In contrast, EE stems from haematogen-
ous spread of pathogens and represents 2% to 5% of all cases.1
The microbial spectrum of endophthalmitis depends on the
cause, geographic location and population studied. In the
Western population, coagulase negative staphylococci and
Streptococcus viridans are the most commonly isolated microor-
ganisms in exogenous endophthalmitis. This is in contrast with
endogenous cases, where Aspergillus species and Staphylococcus
aureus are the most frequently recognised causative agents.
β-haemolytic streptococci, which include group A Streptococcus,
are a rare cause of both endogenous and exogenous endophthal-
mitis, accounting for 2.6% of all cases.2
Risk factors for the development of EE are mainly related to
immunosuppression or to procedures that increase the risk for
blood-borne infections. The most common factors include
immunosuppressive diseases, such as diabetes mellitus, HIV
infection and cancer, major surgery, indwelling intravenous
catheters and intravenous drug abuse.3 Persistent or transient
septicaemia can be due to a myriad of conditions. The most
common extraocular foci of infection are liver abscesses, pneu-
monia, endocarditis and soft tissue and urinary tract infections.
There are about 30 reported cases of EE secondary to tissue
infections, most commonly skin and wound infections, cellulitis,
necrotising fasciitis and myositis.1
Lymphoedema is an abnormal accumulation of protein-rich
interstitial ﬂuid, resulting in oedema formation and eventually
in chronic inﬂammation.4 In the present case, the patient pre-
sented chronic secondary lymphoedema resulting from mastec-
tomy with adjuvant axillary lymph nodes dissection due to
breast cancer. Lymphoedema is a major risk factor for the devel-
opment of erysipelas, an infection of the dermis and dermal
lymphatics commonly caused by streptococcal species, usually
group A streptococci.5 Clinically, it manifests as a ﬁery red,
painful plaque with well-demarcated edges. Once the aetio-
logical agent has broken through the skin, there are no anatom-
ical boundaries limiting its spread through the cutaneous and
subcutaneous tissue. Further resistance to haematogenous spread
of infection depends on the innate and adaptive immune
responses of the host.6 Blood cultures are positive in 4.6% of
patients with erysipelas. Streptococcal species are the predomin-
ant organism identiﬁed, constituting 75% of the isolates from
positive blood cultures (46% group A and 29% non-group A).7
Accordingly, in this case, group A streptococci bacteraemia was
found. Once in the bloodstream, this microorganism may cross
the blood-retinal barrier and access the intraocular structures.
The functional prognosis of EE has not improved in the past
decades despite a better understanding of its physiopathological
mechanisms. Only 29% of patients present a ﬁnal visual acuity
better than counting ﬁngers, while 24% have no light percep-
tion.1 Not surprisingly, even with early recognition, and prompt
intravitreal and systemic antibiotic administration with reso-
lution of the infectious process, the visual outcome in our
patient was poor.
To the best of our knowledge, this is the second reported case
of acute endophthalmitis secondary to erysipelas. Paquier-Vallete
et al8 described a 57-year-old man in whom endophthalmitis was
secondary to Streptococcus agalactiae septicaemia due to erysip-
elas in the left lower limb. As in our case, the patient was treated
with intravitreal ceftazidime and vancomycin. Systemic anti-
biotherapy consisted of imipenem and levoﬂoxacin. The authors
reported complete visual recovery after 1 month of follow-up.
In conclusion, a multidisciplinary approach to EE is of the
utmost importance so that an occult source of infection is not
overlooked. Cutaneous infection, although an extremely rare
cause of EE, should be kept in mind when managing these
cases. Despite prompt and aggressive treatment, the visual
outcome remains poor.
Learning points
▸ Patients with systemic infection who develop visual
symptoms attributable to endogenous endophthalmitis
should be promptly evaluated by an ophthalmologist.
▸ Endophthalmitis secondary to cutaneous infection is a rare
occurrence but should be kept in mind when no other
sources of infection can be found.
▸ A multidisciplinary approach is of paramount importance
when managing endogenous endophthalmitis.
▸ Despite optimal medical care and early recognition, the
visual prognosis is usually poor.
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